Breaking News

AbbVie Announces $1.4B Investment in North Carolina

Will establish a 185-acre pharmaceutical manufacturing campus in Durham, NC.

Author Image

By: Charlie Sternberg

Associate Editor

AbbVie is investing $1.4 billion to build a 185-acre pharmaceutical manufacturing campus in Durham, North Carolina, which will integrate advanced manufacturing and laboratory technologies with artificial intelligence (AI) to support the production of AbbVie’s immunology, neuroscience and oncology medicines. This marks AbbVie’s first major investment in North Carolina. The AbbVie Durham campus, located near Research Triangle Park, was selected for the strength of the region’s...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters